Andrew J. Muir

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Dongliang Ge, Jacques Fellay, Alexander Thompson et al. · Nature · 2009 · 3.5K citations · Full text

Life Sciences, Genetics, Immunology +13

Modification and validation of the Birmingham Vasculitis Activity Score (version 3)

Chetan Mukhtyar, R Lee, Denise Scott Brown et al. · Annals of the Rheumatic Diseases · 2008 · 1.2K citations

Medicine, Cancer Biology, Oncology +14

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

John G. McHutchison, Eric Lawitz, Mitchell L. Shiffman et al. · New England Journal of Medicine · 2009 · 1.2K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection

John G. McHutchison, Gregory T. Everson, Stuart C. Gordon et al. · New England Journal of Medicine · 2009 · 1.1K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis

Michael P. Curry, Jacqueline G. O’Leary, Natalie Bzowej et al. · New England Journal of Medicine · 2015 · 806 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17